<?xml version="1.0" encoding="UTF-8"?>
<feed xmlns="http://www.w3.org/2005/Atom">
  <title>Open Congress : Blog Articles for S.2210 Medical Innovation Prize Act of 2007</title>
  <link href="http://www.opencongress.org/bill/110-s2210/atom_blogs" rel="self"/>
  <link href="http://www.opencongress.org/bill/110-s2210/blogs" rel="alternate"/>
  <updated>2008-11-18T00:00:00Z</updated>
  <author>
    <name>opencongress.org</name>
  </author>
  <id>tag:opencongress.org,2007:/bill/blog/46858</id>
  <entry>
    <title>HIF on the Sanders prize fund bill - Knowledge Ecology Notes</title>
    <link href="http://www.keionline.org/blogs/2008/11/18/hif-on-sanders-prize-fund/" rel="alternate"/>
    <id>tag:opencongress.org,2008-11-18:/commentary/3396135</id>
    <updated>2008-11-18T00:00:00Z</updated>
    <author>
      <name>Knowledge Ecology Notes </name>
    </author>
    <content type="html">
In their recent book on the Health Impact Fund,* Aidan Hollis and Thomas Pogge discuss a number of issues. This is what they say about S.2210 (110th Congress), Senator Sanders&#226;&#8364;&#8482; proposal for the Medical Innovation Prize Fund. ...&lt;br /&gt;&lt;br /&gt;&lt;a href=&quot;http://www.keionline.org/blogs/2008/11/18/hif-on-sanders-prize-fund/&quot;&gt;Go to article&lt;/a&gt;    </content>
  </entry>
  <entry>
    <title>The Health Impact Fund and product monopolies</title>
    <link href="http://www.keionline.org/blogs/2008/11/17/health-impact-fund-monopolies/" rel="alternate"/>
    <id>tag:opencongress.org,2008-11-17:/commentary/3317436</id>
    <updated>2008-11-17T00:00:00Z</updated>
    <author>
      <name>Knowledge Ecology Notes </name>
    </author>
    <content type="html">
... and which were incorporated in the two Sanders bills (HR 417, 109th Congress, S.2210, 110th Congress) and a variety of other proposals, including those most recently advanced by Barbados and Bolivia in the WHO discussions. ...&lt;br /&gt;&lt;br /&gt;&lt;a href=&quot;http://www.keionline.org/blogs/2008/11/17/health-impact-fund-monopolies/&quot;&gt;Go to article&lt;/a&gt;    </content>
  </entry>
  <entry>
    <title>John McCain&#226;&#8364;&#8482;s Prize System: $300 Million for Battery Power</title>
    <link href="http://www.patentlyo.com/patent/2008/06/john-mccains-pr.html" rel="alternate"/>
    <id>tag:opencongress.org,2008-06-24:/commentary/2387259</id>
    <updated>2008-06-24T00:00:00Z</updated>
    <author>
      <name>Patent Law Blog (Patently-O) </name>
    </author>
    <content type="html">
Now Pending S.2210 is the &amp;quot;Medical Innovation Prize Act of 2007.&amp;quot; The act would attempt to &amp;quot;de-couple&amp;quot; the reward for pharmaceutical product research from the market price of the product. Unlike more traditional prizes, this one would .&lt;br /&gt;&lt;br /&gt;&lt;a href=&quot;http://www.patentlyo.com/patent/2008/06/john-mccains-pr.html&quot;&gt;Go to article&lt;/a&gt;    </content>
  </entry>
  <entry>
    <title>James Love: University patent managers versus developing countries</title>
    <link href="http://www.huffingtonpost.com/james-love/university-patent-manager_b_97602.html" rel="alternate"/>
    <id>tag:opencongress.org,2008-04-20:/commentary/2079846</id>
    <updated>2008-04-20T00:00:00Z</updated>
    <author>
      <name>The Full Feed from HuffingtonPost.com </name>
    </author>
    <content type="html">
A number of experts agree with this approach, which is also set forth in S.2210, the Medical Innovation Prize Fund. The debate in the WHO is actually much more limited. For example, Barbados and Bolivia recently proposed five different ...&lt;br /&gt;&lt;br /&gt;&lt;a href=&quot;http://www.huffingtonpost.com/james-love/university-patent-manager_b_97602.html&quot;&gt;Go to article&lt;/a&gt;    </content>
  </entry>
  <entry>
    <title>James Love: University Patent Managers Versus Developing Countries</title>
    <link href="http://feeds.huffingtonpost.com/~r/HP/Business/~3/273823138/university-patent-manager_b_97592.html" rel="alternate"/>
    <id>tag:opencongress.org,2008-04-19:/commentary/2136208</id>
    <updated>2008-04-19T00:00:00Z</updated>
    <author>
      <name>Business on HuffingtonPost.com </name>
    </author>
    <content type="html">
A number of experts agree with this approach, which is also set forth in S.2210, the Medical Innovation Prize Fund. The debate in the WHO is actually much more limited. For example, Barbados and Bolivia recently proposed five different ...&lt;br /&gt;&lt;br /&gt;&lt;a href=&quot;http://feeds.huffingtonpost.com/~r/HP/Business/~3/273823138/university-patent-manager_b_97592.html&quot;&gt;Go to article&lt;/a&gt;    </content>
  </entry>
  <entry>
    <title>Thomson corp</title>
    <link href="http://swordsintheangel.webloog.com/2008/04/19/thomson-corp/" rel="alternate"/>
    <id>tag:opencongress.org,2008-04-19:/commentary/2126560</id>
    <updated>2008-04-19T00:00:00Z</updated>
    <author>
      <name>Swords in the Angel </name>
    </author>
    <content type="html">
A number of experts agree with this approach, which is also set forth in S.2210, the Medical Innovation Prize Fund. The debate in the WHO is actually much more limited. For example, Barbados and Bolivia recently proposed five different ...&lt;br /&gt;&lt;br /&gt;&lt;a href=&quot;http://swordsintheangel.webloog.com/2008/04/19/thomson-corp/&quot;&gt;Go to article&lt;/a&gt;    </content>
  </entry>
  <entry>
    <title>A Federally Funded Institute To Compare Drugs? // Pharmalot</title>
    <link href="http://www.pharmalot.com/2008/04/a-federally-funded-institute-to-compare-drugs/" rel="alternate"/>
    <id>tag:opencongress.org,2008-04-01:/commentary/3396138</id>
    <updated>2008-04-01T00:00:00Z</updated>
    <author>
      <name>Pharmalot </name>
    </author>
    <content type="html">
If this tentative legislation was put together with a Medical Innovation Prize Act http://thomas.loc.gov/cgi-bin/query/z?c110:S.2210: instead of the current pricing &amp; reimbursement arrangements then we&#226;&#8364;&#8482;d have better &amp; cheaper medicines ...&lt;br /&gt;&lt;br /&gt;&lt;a href=&quot;http://www.pharmalot.com/2008/04/a-federally-funded-institute-to-compare-drugs/&quot;&gt;Go to article&lt;/a&gt;    </content>
  </entry>
  <entry>
    <title>Workshop Friday on alternative of prizes, not patents, to promote ...</title>
    <link href="http://static.uspirg.org/consumer/archives/2008/02/workshop_friday.html" rel="alternate"/>
    <id>tag:opencongress.org,2008-02-06:/commentary/1581246</id>
    <updated>2008-02-06T00:00:00Z</updated>
    <author>
      <name>US PIRG Consumer Blog </name>
    </author>
    <content type="html">
This will include, but not be limited to, a discussion of the proposed Medical Prize Fund Act of 2007 (S.2210, 110th Congress) introduced by US Senator Bernie Sanders. As I pointed out recently:. &amp;quot;It is natural for consumers to distrust ...&lt;br /&gt;&lt;br /&gt;&lt;a href=&quot;http://static.uspirg.org/consumer/archives/2008/02/workshop_friday.html&quot;&gt;Go to article&lt;/a&gt;    </content>
  </entry>
  <entry>
    <title>&#208;&#376;&#209;&#8364;&#208;&#190; &#208;&#188;&#208;&#181;&#208;&#180;&#208;&#184;&#209;&#8225;&#208;&#189;&#209;&#8211; &#208;&#178;&#208;&#184;&#208;&#189;&#208;&#176;&#209;&#8230;&#208;&#190;&#208;&#180;&#208;&#184;</title>
    <link href="http://irynak.livejournal.com/104190.html" rel="alternate"/>
    <id>tag:opencongress.org,2008-02-05:/commentary/1569933</id>
    <updated>2008-02-05T00:00:00Z</updated>
    <author>
      <name>&#1057;&#1087;&#1110;&#1083;&#1100;&#1085;&#1086;&#1090;&#1072; a2k </name>
    </author>
    <content type="html">
Tim Hubbard, Wellcome Trust Sanger Institute. http://www.keionline.org/misc-docs/Prizes/bigidea_prizes4rnd_kchikent_vol82no3.pdf. David Reynold&amp;#39;s presentation on the US Medical Innovation Prize Fund (S.2210, 110th Congress) ...&lt;br /&gt;&lt;br /&gt;&lt;a href=&quot;http://irynak.livejournal.com/104190.html&quot;&gt;Go to article&lt;/a&gt;    </content>
  </entry>
  <entry>
    <title>Gesch&#195;&#164;ftsordnung Deutscher Bundestag ( GOBT ) Stand 2006</title>
    <link href="http://www.literaturasyl.de/?p=213" rel="alternate"/>
    <id>tag:opencongress.org,2007-12-02:/commentary/1380429</id>
    <updated>2007-12-02T00:00:00Z</updated>
    <author>
      <name>Fun und Spass - Tibia und Politologie </name>
    </author>
    <content type="html">
Gesch&#195;&#164;ftsordnung des Deutschen Bundestages Gesch&#195;&#164;ftsordnung des Deutschen Bundestages in der Fassung der Bekanntmachung vom 2. Juli 1980 (BGBl. I S. 1237), zuletzt ge&#195;&#164;ndert laut Bekanntmachung vom 26. September 2006 (BGBl. I S. 2210)&lt;br /&gt;&lt;br /&gt;&lt;a href=&quot;http://www.literaturasyl.de/?p=213&quot;&gt;Go to article&lt;/a&gt;    </content>
  </entry>
  <entry>
    <title>Sen. Sanders Introduces Bill to End Market Exclusivity and Create ...</title>
    <link href="http://www.fdalawblog.net/fda_law_blog_hyman_phelps/2007/10/sen-sanders-int.html" rel="alternate"/>
    <id>tag:opencongress.org,2007-10-28:/commentary/1291405</id>
    <updated>2007-10-28T00:00:00Z</updated>
    <author>
      <name>FDA Law Blog </name>
    </author>
    <content type="html">
Earlier this month, Senator Bernie Sanders (I-VT) announced the introduction of the &#226;&#8364;&#339;Medical Innovation Prize Act of 2007&#226;&#8364;* (S. 2210). If enacted, the bill would replace the current patent and non-patent market exclusivity system for ...&lt;br /&gt;&lt;br /&gt;&lt;a href=&quot;http://www.fdalawblog.net/fda_law_blog_hyman_phelps/2007/10/sen-sanders-int.html&quot;&gt;Go to article&lt;/a&gt;    </content>
  </entry>
  <entry>
    <title>S. 2210, A bill to provide incentives for investment in research ...</title>
    <link href="http://www.washingtonwatch.com/bills/show/110_SN_2210.html" rel="alternate"/>
    <id>tag:opencongress.org,2007-10-18:/commentary/1262088</id>
    <updated>2007-10-18T00:00:00Z</updated>
    <author>
      <name>WashingtonWatch.com - Welcome to WashingtonWatc... </name>
    </author>
    <content type="html">
S. 2210 would provide incentives for investment in research and development for new medicines, and it would enhance access to new medicines....&lt;br /&gt;&lt;br /&gt;&lt;a href=&quot;http://www.washingtonwatch.com/bills/show/110_SN_2210.html&quot;&gt;Go to article&lt;/a&gt;    </content>
  </entry>
  <entry>
    <title>Bill Action: Introduced: S. 2210: A bill to provide incentives for ...</title>
    <link href="http://www.govtrack.us/congress/bill.xpd?bill=s110-2210" rel="alternate"/>
    <id>tag:opencongress.org,2007-10-18:/commentary/1256650</id>
    <updated>2007-10-18T00:00:00Z</updated>
    <author>
      <name>Active Legislation -- Tracked by GovTrack.us </name>
    </author>
    <content type="html">
Bernard Sanders [I-VT] introduced S. 2210: A bill to provide incentives for investment in research and development for new medicines, to enhance access to new medicines, and for other purposes. [This event matched these trackers: Active ...&lt;br /&gt;&lt;br /&gt;&lt;a href=&quot;http://www.govtrack.us/congress/bill.xpd?bill=s110-2210&quot;&gt;Go to article&lt;/a&gt;    </content>
  </entry>
</feed>
